ATM offering tracker
This ATM offering tracker lists recent at-the-market prospectus supplements filed with the SEC: the 424B5 filings in which a company sets up, resizes or ends a program to sell new shares straight into the market. An ATM lets a company sell stock on any trading day at the market price, so a newly filed or upsized ATM is one of the most direct dilution events a small-cap trader can see. The list covers companies of every size; an ATM matters most where the program is large next to the company's value.
Recent ATM filings
Each row is one 424B5 that Signal8's filing archive tagged as an ATM program change. "Kind" is our reading of the filing's first sentence. The last column shows what Signal8's published dilution summary for that company says about its ATM, with the filing it cites.
| Company | Accepted | Kind | What the filing says | ATM in Signal8 summary | Filing |
|---|---|---|---|---|---|
| HL HECLA MINING CO/DE/ | Nov 10, 2026, 5:14 PM ET | New program | Hecla Mining established a new at-the-market equity program on November 10, 2026 to sell up to 50,000,000 shares of common stock, worth up to approximately $669.5 million, through eight sales agents including BofA Securities, Morgan... | Not measured No published summary for this ticker | 424B5 |
| ENLT Enlight Renewable Energy Ltd. | Nov 10, 2026, 5:12 PM ET | New program | Enlight Renewable Energy filed a 424B5 prospectus supplement establishing a $400 million at-the-market equity program, selling ordinary shares through Barclays Capital and Wells Fargo Securities with commissions of up to 2.0%. | Not measured No published summary for this ticker | 424B5 |
| NHP National Healthcare Properties, Inc. | Nov 10, 2026, 4:53 PM ET | New program | National Healthcare Properties has established a $300 million at-the-market equity offering program dated November 10, 2026, with 14 banks including Goldman Sachs, Morgan Stanley and Wells Fargo acting as sales agents. | Not measured No published summary for this ticker | 424B5 |
| PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Nov 10, 2026, 4:05 PM ET | New program | Pacific Biosciences filed a 424B5 prospectus supplement on November 10, 2026 establishing a $100 million at-the-market equity offering through Allen & Company LLC as sales agent. | Not measured No published summary for this ticker | 424B5 |
| JAGX Jaguar Health, Inc. | Nov 9, 2026, 8:37 AM ET | New program | Jaguar Health filed a 424B5 prospectus supplement for a new $75 million at-the-market offering of common stock through Ladenburg Thalmann, on top of roughly $104 million already sold under prior ATM registrations. | On file Cites 424B5 filed Nov 9, 2026 | 424B5 |
| IIPR INNOVATIVE INDUSTRIAL PROPERTIES INC | Nov 9, 2026, 8:24 AM ET | Amended | Innovative Industrial Properties filed a 424B5 prospectus supplement amending and restating its at-the-market equity program, registering up to $500 million of common stock plus 9.00% Series A and 9.25% Series B Cumulative Redeemable... | Not measured No published summary for this ticker | 424B5 |
| FWDI Forward Industries, Inc. | Nov 9, 2026, 8:07 AM ET | Amended | Forward Industries filed a 424B5 prospectus supplement amending its $4.0 billion at-the-market equity program to add Barclays Capital Inc. alongside Cantor Fitzgerald as sales agents, under an amended and restated Sales Agreement dated... | Not measured No published summary for this ticker | 424B5 |
| USGO U.S. GoldMining Inc. | Nov 6, 2026, 4:34 PM ET | Reduced | U.S. GoldMining filed a prospectus supplement reducing its at-the-market offering capacity to $3.2 million of common stock, sold through H.C. Wainwright, Ventum Financial, and Stifel. | On file Cites 10-Q filed Nov 10, 2026 | 424B5 |
| GNL Global Net Lease, Inc. | Nov 6, 2026, 4:30 PM ET | Amended | Global Net Lease filed Supplement No. 1 to its November 2025 ATM prospectus supplement for its $300 million common stock at-the-market offering program. | Not measured No published summary for this ticker | 424B5 |
| AHR American Healthcare REIT, Inc. | Nov 6, 2026, 4:29 PM ET | New program | American Healthcare REIT filed a 424B5 prospectus supplement establishing a new $1.75 billion at-the-market equity program with forward sale capability, dated November 6, 2026, through ten agents including BofA Securities, Citigroup and... | Not measured No published summary for this ticker | 424B5 |
| ZBIO Zenas BioPharma, Inc. | Nov 6, 2026, 4:15 PM ET | New program | Zenas BioPharma filed a new $200 million at-the-market offering prospectus supplement through Jefferies, terminating the prior October 2025 ATM under which approximately $153.2 million had already been sold. | Not measured No published summary for this ticker | 424B5 |
| ATYR aTYR PHARMA INC | Nov 6, 2026, 4:05 PM ET | Amended | aTyr Pharma filed a 424B5 prospectus supplement refreshing its at-the-market offering, covering up to $79,994,251 of unsold common stock sales through Jefferies at a 3.0% commission, as part of a $215.0 million total sales agreement. | On file Cites 424B5 filed Nov 6, 2026 | 424B5 |
| IRON Disc Medicine, Inc. | Nov 5, 2026, 5:20 PM ET | New program | Disc Medicine filed a 424B5 prospectus supplement establishing a $189,925,765 at-the-market offering through TD Cowen, with an assumed price of $83.28 per share (the November 4, 2026 close). | Not measured No published summary for this ticker | 424B5 |
| FATE FATE THERAPEUTICS INC | Nov 5, 2026, 4:36 PM ET | New program | Fate Therapeutics filed a 424B5 prospectus supplement establishing a new $100 million at-the-market offering through Leerink Partners, terminating its prior ATM agreement with Jefferies in the process. | On file Cites 424B5 filed Nov 5, 2026 | 424B5 |
| AVTX Avalo Therapeutics, Inc. | Nov 5, 2026, 7:51 AM ET | New program | Avalo Therapeutics filed a prospectus supplement on November 5, 2026 establishing a $200 million at-the-market offering of common stock through Jefferies LLC, its sole sales agent under an Open Market Sale Agreement dated the same day. | Not measured No published summary for this ticker | 424B5 |
| DDD 3D SYSTEMS CORP | Nov 5, 2026, 7:19 AM ET | New program | 3D Systems filed a 424B5 prospectus supplement establishing a $42.5 million at-the-market offering of common stock through Cantor Fitzgerald, with commissions up to 3.0% and an assumed price of $2.64 per share. | Not measured No published summary for this ticker | 424B5 |
| BIVI BIOVIE INC. | Nov 4, 2026, 9:06 PM ET | Amended | BioVie Inc. (BIVI) filed Amendment No. 2 to its prospectus supplement, slashing the remaining capacity under its at-the-market equity program with A.G.P./Alliance Global Partners from $1,225,000 down to $285,000. | On file Cites 10-Q filed Nov 6, 2026 | 424B5 |
| QNRX Quoin Pharmaceuticals Ltd. | Nov 4, 2026, 5:14 PM ET | New program | Quoin Pharmaceuticals (QNRX) filed a prospectus supplement establishing an at-the-market offering of up to $11.0 million of ADSs through Leerink Partners, at a 3.0% commission. | On file Cites 10-Q filed Nov 5, 2026 | 424B5 |
| WEC WEC ENERGY GROUP, INC. | Nov 4, 2026, 5:10 PM ET | New program | WEC Energy Group filed a 424B5 prospectus supplement establishing a $4.0 billion at-the-market equity distribution agreement, allowing it to sell common stock over time through 15 sales agents including Barclays, BofA Securities, and... | Not measured No published summary for this ticker | 424B5 |
| DSGN Design Therapeutics, Inc. | Nov 4, 2026, 4:27 PM ET | Upsized | Design Therapeutics doubled its at-the-market equity offering capacity to $200 million via a 424B5 prospectus supplement filed November 4, 2026, with Jefferies acting as sales agent. | Not measured No published summary for this ticker | 424B5 |
| ARQT Arcutis Biotherapeutics, Inc. | Nov 4, 2026, 4:17 PM ET | New program | Arcutis Biotherapeutics filed a 424B5 prospectus supplement establishing a new $200 million at-the-market equity program, selling common stock through TD Cowen as agent at up to 3.0% commission. | Not measured No published summary for this ticker | 424B5 |
| BIVI BIOVIE INC. | Nov 4, 2026, 7:50 AM ET | Amended | BioVie filed Amendment No. 1 to its September 2026 prospectus supplement, cutting the maximum amount of Class A common stock it may sell through A.G.P./Alliance Global Partners under its ATM sales agreement from $6,464,341 to $1,225,000. | On file Cites 10-Q filed Nov 6, 2026 | 424B5 |
| AKR ACADIA REALTY TRUST | Nov 3, 2026, 4:43 PM ET | Amended | Acadia Realty Trust filed a 424B5 prospectus supplement on November 3, 2026 amending its $500 million ATM equity offering sales agreement dated February 14, 2025, adding Citizens JMP Securities as a sales agent and forward purchaser. | Not measured No published summary for this ticker | 424B5 |
| BIAF bioAffinity Technologies, Inc. | Nov 3, 2026, 4:38 PM ET | Upsized | bioAffinity Technologies filed a 424B5 prospectus supplement increasing its at-the-market offering capacity by up to $5,228,226 of common stock, sold through WallachBeth Capital under its May 2025 sales agreement. | On file Cites 10-Q filed Nov 6, 2026 | 424B5 |
| OCS Oculis Holding AG | Nov 3, 2026, 4:30 PM ET | Upsized | Oculis Holding AG filed a prospectus supplement increasing the capacity of its at-the-market (ATM) equity program with Leerink Partners from $100 million to $125 million. | Not measured No published summary for this ticker | 424B5 |
| DOCN DigitalOcean Holdings, Inc. | Nov 3, 2026, 9:15 AM ET | New program | DigitalOcean filed a 424B5 prospectus supplement establishing a $1.0 billion at-the-market equity program under an equity distribution agreement dated November 2, 2026, with Goldman Sachs, J.P. Morgan, Morgan Stanley, BofA, MUFG, Citizens... | Not measured No published summary for this ticker | 424B5 |
| BIAF bioAffinity Technologies, Inc. | Nov 2, 2026, 4:52 PM ET | Upsized | bioAffinity Technologies filed a 424B5 prospectus supplement on November 2, 2026, increasing its at-the-market offering capacity by $3,428,226, bringing the total registered under the supplement to $5,228,226 of common stock. | On file Cites 10-Q filed Nov 6, 2026 | 424B5 |
| PRCH Porch Group, Inc. | Oct 30, 2026, 5:17 PM ET | New program | Porch Group filed a 424B5 prospectus supplement establishing an at-the-market offering of up to 15 million PRCH shares through StoneX Financial at a 1.5% commission. | Not measured No published summary for this ticker | 424B5 |
| APVO Aptevo Therapeutics Inc. | Oct 30, 2026, 4:36 PM ET | Upsized | Aptevo Therapeutics filed a 424B5 prospectus supplement on October 30, 2026 amending its at-the-market offering program with Roth Capital Partners, restoring capacity to sell up to $2,309,834 of additional common stock. | On file Cites 424B5 filed Oct 30, 2026 | 424B5 |
| XEL XCEL ENERGY INC | Oct 30, 2026, 4:33 PM ET | New program | Xcel Energy filed a 424B5 prospectus supplement establishing a new at-the-market equity program of up to $6.0 billion of common stock, with sales through Barclays, BofA, Goldman Sachs, J.P. Morgan, Morgan Stanley, Wells Fargo and other... | Not measured No published summary for this ticker | 424B5 |
| PLD Prologis, Inc. | Oct 30, 2026, 4:01 PM ET | New program | Prologis has filed a 424B5 prospectus supplement establishing a new $5.0 billion at-the-market equity program under an equity distribution agreement dated October 30, 2026, with 26 managers including BofA, Goldman Sachs, J.P. Morgan and... | Not measured No published summary for this ticker | 424B5 |
| VOR Vor Biopharma Inc. | Oct 30, 2026, 8:45 AM ET | New program | Vor Biopharma entered into a $150 million at-the-market offering agreement with William Blair and RBC Capital Markets dated October 30, 2026, replacing its prior $125 million Stifel ATM which was fully utilized and expired. | Not measured No published summary for this ticker | 424B5 |
| AUR Aurora Innovation, Inc. | Oct 28, 2026, 4:31 PM ET | New program | Aurora Innovation amended and upsized its at-the-market equity offering program to $1.0 billion via a 424B5 prospectus supplement amendment, adding $754.2 million in new selling capacity. | Not measured No published summary for this ticker | 424B5 |
| OGE OGE ENERGY CORP. | Oct 28, 2026, 4:22 PM ET | New program | OGE Energy Corp. has established a new at-the-market equity program allowing it to sell up to $750 million of common stock from time to time under an equity distribution agreement dated October 28, 2026, with twelve sales agents including... | Not measured No published summary for this ticker | 424B5 |
| CTO CTO Realty Growth, Inc. | Oct 28, 2026, 4:15 PM ET | Amended | CTO Realty Growth filed a prospectus supplement adding BofA Securities as a sales agent, forward seller, and forward purchaser under its existing $250 million at-the-market equity program, and amending the distribution agreements with its... | Not measured No published summary for this ticker | 424B5 |
| OSS ONE STOP SYSTEMS, INC. | Oct 28, 2026, 9:12 AM ET | New program | One Stop Systems filed a 424B5 establishing a $50 million at-the-market equity program with Piper Sandler as sales agent, selling common stock from time to time at prevailing market prices with commissions up to 3.0%. | On file Cites 424B5 filed Oct 28, 2026 | 424B5 |
| XXII 22nd Century Group, Inc. | Oct 28, 2026, 6:05 AM ET | Amended | 22nd Century Group filed a 424B5 prospectus supplement solely to add Clear Street LLC as a sales agent under its existing at-the-market offering program of up to $18.8 million of common stock, alongside incumbent agent Needham & Company. | On file Cites 424B5 filed Oct 28, 2026 | 424B5 |
| ASST Strive, Inc. | Oct 26, 2026, 7:45 AM ET | New program | Strive, Inc. filed a 424B5 prospectus supplement on October 26, 2026 launching an at-the-market offering of up to $1 billion of additional 15.00% Series A Perpetual SATS Preferred Stock through seven agents, led by Cantor Fitzgerald and... | Not measured No published summary for this ticker | 424B5 |
| IMRN Immuron Ltd | Oct 23, 2026, 5:24 PM ET | Amended | Immuron Limited filed a prospectus supplement to its July 2024 at-the-market offering agreement with H.C. Wainwright, decreasing the maximum aggregate offering to approximately $2,006,769. | On file Cites 424B5 filed Oct 23, 2026 | 424B5 |
| XXII 22nd Century Group, Inc. | Oct 23, 2026, 5:24 PM ET | New program | 22nd Century Group filed a 424B5 prospectus supplement registering an at-the-market offering of up to $18.8 million of common stock through Needham & Company under its November 2025 sales agreement. | On file Cites 424B5 filed Oct 28, 2026 | 424B5 |
| UFG Uni-Fuels Holdings Ltd | Oct 23, 2026, 5:13 PM ET | New program | Uni-Fuels Holdings (UFG) filed a 424B5 prospectus supplement on October 23, 2026 launching an at-the-market offering of up to US$2,354,291 in Class A ordinary shares through Rodman & Renshaw, with a 3.0% placement fee. | On file Cites 6-K filed Oct 26, 2026 | 424B5 |
| PINE Alpine Income Property Trust, Inc. | Oct 23, 2026, 4:21 PM ET | New program | Alpine Income Property Trust (PINE) filed a prospectus supplement establishing a $150 million at-the-market equity program dated October 23, 2026, with 16 sales agents including Raymond James, Jefferies, Stifel and UBS. The program... | On file Cites 424B5 filed Oct 23, 2026 | 424B5 |
| PINE Alpine Income Property Trust, Inc. | Oct 23, 2026, 4:19 PM ET | New program | Alpine Income Property Trust filed a 424B5 establishing a new at-the-market program to sell up to $35 million of its 8.00% Series A Cumulative Redeemable Preferred Stock (NYSE: PINE/PA) through twelve sales agents, with commissions capped... | On file Cites 424B5 filed Oct 23, 2026 | 424B5 |
| AXG Solowin Holdings, Ltd. | Oct 22, 2026, 5:31 PM ET | New program | Solowin Holdings filed a 424B5 establishing a $50 million at-the-market equity program through Chaince Securities, dated October 22, 2026, with shares sold at market prices on Nasdaq under the symbol AXG. The last closing price was... | On file Cites 424B5 filed Nov 6, 2026 | 424B5 |
| AEHL Antelope Enterprise Holdings Ltd | Oct 22, 2026, 9:00 AM ET | Amended | Antelope Enterprise Holdings filed Amendment No. 1 to its October 1, 2026 prospectus supplement for its $100 million at-the-market offering with D. Boral Capital as sales agent. | Not measured No published summary for this ticker | 424B5 |
| SLE Super League Enterprise, Inc. | Oct 21, 2026, 5:15 PM ET | Upsized | Super League Enterprise amended its ATM prospectus supplements to increase the amount it may sell under its Sales Agreement with Benchmark and StoneX by $950,000, bringing the aggregate capacity to $6,421,000. | On file Cites 424B5 filed Oct 21, 2026 | 424B5 |
| QNME Quanome Technologies, Inc. | Oct 21, 2026, 4:05 PM ET | New program | Quanome Technologies (formerly Lakeside Holding Limited; Nasdaq: QNME) filed a 424B5 on October 21, 2026 establishing an at-the-market offering of up to $9,754,475 of common stock (up to 20,579,061 shares at the assumed $0.474 price)... | On file Cites 8-K filed Oct 21, 2026 | 424B5 |
| NNVC NANOVIRICIDES, INC. | Oct 21, 2026, 10:15 AM ET | Amended | Nanoviricides filed Amendment No. 2 to its July 2026 ATM prospectus supplement, restoring approximately $2.37 million of sellable capacity under its at-the-market offering with D. Boral Capital LLC. The cap reset is driven by the General... | On file Cites 424B5 filed Oct 21, 2026 | 424B5 |
| TGL TREASURE GLOBAL INC | Oct 20, 2026, 9:33 PM ET | Amended | Treasure Global Inc filed a 424B5 prospectus supplement amending its $10.085 million at-the-market offering with Kingswood Capital Partners, raising the agent's commission to 4.5% of gross proceeds for sales made from October 15 through... | On file Cites 424B5 filed Oct 21, 2026 | 424B5 |
| TNON Tenon Medical, Inc. | Oct 16, 2026, 4:23 PM ET | Upsized | Tenon Medical filed a prospectus supplement amending its ATM offering with A.G.P./Alliance Global Partners, increasing the maximum amount it can sell to $7,176,045 under General Instruction I.B.6 of Form S-3. The company has already sold... | On file Cites 8-K filed Oct 22, 2026 | 424B5 |
| TRON Tron Inc. | Oct 14, 2026, 5:30 PM ET | New program | Tron Inc. filed a 424B5 prospectus supplement establishing a $200 million at-the-market equity program with Clear Street LLC, dated October 14, 2026, selling common stock from time to time at prevailing market prices. | Not measured No published summary for this ticker | 424B5 |
| MOVE Corvex, Inc. | Oct 14, 2026, 4:30 PM ET | New program | Corvex, Inc. (Nasdaq: MOVE) filed a 424B5 prospectus supplement establishing a $250 million at-the-market equity offering through Chardan Capital Markets, which will earn a 2.5% commission on gross proceeds, with net proceeds earmarked for... | On file Cites 424B5 filed Oct 14, 2026 | 424B5 |
| BRNX BRENX LTD. | Oct 14, 2026, 4:30 PM ET | New program | BrenX Ltd. filed a 424B5 prospectus supplement establishing an at-the-market offering of up to $2,886,058 of ordinary shares through A.G.P./Alliance Global Partners at a 3.0% commission, under its $75 million F-3 shelf. | On file Cites 424B5 filed Oct 14, 2026 | 424B5 |
| UUUU ENERGY FUELS INC | Oct 13, 2026, 5:28 PM ET | New program | Energy Fuels filed a 424B5 prospectus supplement establishing up to $500 million of at-the-market sales of common shares through BMO, Canaccord, Cantor, B. Riley and H.C. Wainwright, with agents earning up to 3.0% commission. | Not measured No published summary for this ticker | 424B5 |
| RDHL RedHill Biopharma Ltd. | Oct 13, 2026, 4:06 PM ET | Upsized | RedHill Biopharma filed Prospectus Supplement No. 5 to increase the capacity under its at-the-market offering with H.C. Wainwright, registering up to $2,587,409 of additional ADS sales. | On file Cites 424B5 filed Oct 13, 2026 | 424B5 |
| CENN Cenntro Inc. | Oct 13, 2026, 8:30 AM ET | Amended | Cenntro Inc. filed a prospectus supplement for a $100 million at-the-market equity offering through Pacific Century Securities, dated October 9, 2026, paying a 3.5% commission on gross proceeds. | On file Cites 8-K filed Oct 15, 2026 | 424B5 |
| GPUS Hyperscale Data, Inc. | Oct 13, 2026, 6:26 AM ET | Reduced | Hyperscale Data filed Supplement No. 1 to its prospectus supplement on October 13, 2026, reducing the maximum aggregate amount of Class A Common Stock sellable under its ATM with Spartan Capital from $300 million to $100 million. | On file Cites 424B5 filed Nov 6, 2026 | 424B5 |
| QUCY Quantum Cyber N.V. | Oct 9, 2026, 5:15 PM ET | New program | Quantum Cyber N.V. (Nasdaq: QUCY) filed a prospectus supplement establishing a $100 million at-the-market equity offering through Titan Partners Securities, with a 3% commission on gross sales. | On file Cites 8-K filed Oct 9, 2026 | 424B5 |
| NIKI Niki BioSolutions, Inc. | Oct 9, 2026, 5:09 PM ET | New program | Niki BioSolutions, Inc. (Nasdaq: NIKI) filed a 424B5 establishing a $1,396,000 at-the-market equity program through H.C. Wainwright, capped at one-third of its ~$10.2M public float under Form S-3 baby-shelf rules. | On file Cites 8-K filed Oct 9, 2026 | 424B5 |
| HSCS HeartSciences Inc. | Oct 9, 2026, 5:00 PM ET | Upsized | HeartSciences filed Prospectus Supplement No. 4 to its at-the-market offering, registering up to $4,161,139 of additional common stock sales capacity under the EDA with Maxim Group LLC. Combined with prior sales, the total EDA program now... | On file Cites 424B5 filed Oct 9, 2026 | 424B5 |
| SBLK Star Bulk Carriers Corp. | Oct 9, 2026, 4:39 PM ET | New program | Star Bulk Carriers filed a 424B5 establishing a new $75 million at-the-market equity program with Jefferies, dated October 9, 2026, replacing a prior $75 million ATM under which no shares had been sold. | Not measured No published summary for this ticker | 424B5 |
| IDAI T Stamp Inc | Oct 9, 2026, 4:37 PM ET | New program | T Stamp Inc. (Nasdaq: IDAI) filed a 424B5 prospectus supplement dated October 9, 2026 establishing a new at-the-market offering of up to $5,323,474 of common stock through Maxim Group LLC as sales agent, earning up to a 3.0% commission. | On file Cites 424B5 filed Oct 9, 2026 | 424B5 |
| SBLK Star Bulk Carriers Corp. | Oct 9, 2026, 4:34 PM ET | New program | Star Bulk Carriers filed a 424B5 prospectus supplement establishing a new at-the-market program to sell up to $41.37 million of common shares through Deutsche Bank Securities, replacing its prior ATM under which 937,882 shares had been... | Not measured No published summary for this ticker | 424B5 |
| SURG SurgePays, Inc. | Oct 9, 2026, 4:30 PM ET | Amended | SurgePays filed a 424B5 prospectus supplement on October 9, 2026 to update its existing at-the-market offering program. | On file Cites 424B5 filed Oct 9, 2026 | 424B5 |
| RYDE Ryde Group Ltd | Oct 9, 2026, 4:10 PM ET | New program | Ryde Group Ltd filed a 424B5 prospectus supplement dated October 9, 2026 establishing a $96.4 million at-the-market offering of Class A ordinary shares through Arc Group Securities LLC, with a 2.5% commission on gross sales. | On file Cites 424B5 filed Oct 9, 2026 | 424B5 |
| BIAF bioAffinity Technologies, Inc. | Oct 9, 2026, 11:26 AM ET | Reduced | bioAffinity Technologies filed Supplement No. 1 to its May 2025 ATM prospectus supplement, reducing the dollar amount of common stock it may sell under the WallachBeth Capital ATM agreement to zero. | On file Cites 10-Q filed Nov 6, 2026 | 424B5 |
| ZENA ZenaTech, Inc. | Oct 8, 2026, 8:57 PM ET | Upsized | ZenaTech filed a prospectus supplement doubling its at-the-market offering capacity from US$75 million to US$150 million through sales agents Maxim Group and Northland Securities, at prices at or near the October 7, 2026 Nasdaq close of... | On file Cites 424B5 filed Oct 9, 2026 | 424B5 |
| INV Innventure, Inc. | Oct 6, 2026, 5:28 PM ET | New program | Innventure, Inc. filed a 424B5 prospectus supplement on October 6, 2026 establishing a $60 million at-the-market offering through Lucid Capital Markets, with estimated net proceeds of $58.2 million. | On file Cites PR filed Nov 2, 2026 | 424B5 |
| YFOR YYForce Inc. | Oct 5, 2026, 4:36 PM ET | New program | YYForce Inc. (formerly YY Group Holding, ticker changed from YYGH to YFOR on September 2, 2026) filed a 424B5 launching a new at-the-market offering of up to $20,000,000 of Class A ordinary shares through Spartan Capital Securities, which... | On file Cites 424B5 filed Oct 5, 2026 | 424B5 |
| STKH Steakholder Foods Ltd. | Oct 5, 2026, 4:15 PM ET | Amended | Steakholder Foods filed a 424B5 prospectus supplement on October 5, 2026 refreshing its at-the-market facility with H.C. Wainwright, enabling sales of up to $4,036,262 of ADSs under General Instruction I.B.5 of Form F-3. The company has... | On file Cites 424B5 filed Oct 5, 2026 | 424B5 |
What an ATM offering is
An at-the-market offering is a program in which a company appoints a sales agent, usually an investment bank, to sell newly issued shares into the open market over time. It is set up under an effective shelf registration (Form S-3 or F-3), and the company files a prospectus supplement on Form 424B5 naming the agent and the maximum dollar amount it may sell. The company then reports how much it actually sold in its next 10-Q or 10-K, or sometimes in an 8-K.
Three things to read in any ATM filing: the maximum amount, compared with the company's market value; whether the company is limited by the "baby shelf" rule (General Instruction I.B.6 of Form S-3), which caps sales at one third of public float in any 12 months for companies with under $75 million of public float; and the agent's commission, usually up to 3%.
How this tracker is built
Rows come from Signal8's archive of SEC filings, which records every 424B5 with its acceptance time and an AI-written summary. We keep a 424B5 when the first sentence of its summary describes an at-the-market program, and drop debt-only financings. The summary sentence is shown as written by the model; the filing link is the source. Read the filing before you rely on any row. Full method: methodology.
To see a company's whole dilution picture, warrants and convertibles included, open its page on DilutionScan, the Signal8 dilution tracker this site picks.